Literature DB >> 10882703

Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of pseudomonas aeruginosa: a French multicentre study (1996).

J D Cavallo1, R Fabre, F Leblanc, M H Nicolas-Chanoine, A Thabaut.   

Abstract

A total of 1310 consecutive strains of Pseudomonas aeruginosa were collected in 11 French hospitals in 1996. The percentages of susceptible isolates measured by the agar dilution method were: ticarcillin (53%), piperacillin (69%) (MIC 16 mg/L), ceftazidime (77%), cefepime (55%), cefpirome (40%), aztreonam (57.5%), imipenem (81.5%) (MIC 4 mg/L), amikacin (64.5%) (MIC 8 mg/L) and ciprofloxacin (58%) (MIC 1 mg/L). Resistance to beta-lactams was linked to the production of transferable beta-lactamases (30%), overproduction of cephalosporinase (29%) and to non-enzymic mechanisms (38%).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882703     DOI: 10.1093/jac/46.1.133

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Deletion mutations conferring substrate spectrum extension in the class A β-lactamase.

Authors:  Junghyun Hwang; Kwang-Hwi Cho; Han Song; Hyojeong Yi; Heenam Stanley Kim
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

2.  Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.

Authors:  Didier Hocquet; Patrice Nordmann; Farid El Garch; Ludovic Cabanne; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

3.  Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients.

Authors:  Robert Sauermann; Georg Delle-Karth; Claudia Marsik; Ilka Steiner; Markus Zeitlinger; Bernhard X Mayer-Helm; Apostolos Georgopoulos; Markus Müller; Christian Joukhadar
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Comparable population pharmacokinetics and pharmacodynamic breakpoints of cefpirome in cystic fibrosis patients and healthy volunteers.

Authors:  J B Bulitta; M Kinzig; C B Landersdorfer; U Holzgrabe; U Stephan; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

5.  Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase.

Authors:  C Peña; C Suarez; F Tubau; C Juan; B Moya; M A Dominguez; A Oliver; M Pujol; J Ariza
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

Review 6.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

7.  Prospective survey of beta-lactamases produced by ceftazidime- resistant Pseudomonas aeruginosa isolated in a French hospital in 2000.

Authors:  Christophe De Champs; Laurent Poirel; Richard Bonnet; Danielle Sirot; Catherine Chanal; Jacques Sirot; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

8.  Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.

Authors:  O Gutiérrez; C Juan; E Cercenado; F Navarro; E Bouza; P Coll; J L Pérez; A Oliver
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

9.  Evaluation of the Osiris expert system for identification of beta-lactam phenotypes in isolates of Pseudomonas aeruginosa.

Authors:  Frédéric Bert; Zahia Ould-Hocine; Manette Juvin; Véronique Dubois; Véronique Loncle-Provot; Valérie Lefranc; Claudine Quentin; Nicole Lambert; Guillaume Arlet
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

10.  The characteristics of metallo-β-lactamase-producing gram-negative bacilli isolated from sputum and urine: a single center experience in Korea.

Authors:  Bum Sik Chin; Sang Hoon Han; Suk Hoon Choi; Han Sung Lee; Su Jin Jeong; Hee Kyung Choi; Jun Yong Choi; Young Goo Song; Chang Ki Kim; Dongeun Yong; Kyungwon Lee; June Myung Kim
Journal:  Yonsei Med J       Date:  2011-03       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.